Farnesoid X receptor regulates the growth of renal adenocarcinoma cells without affecting that of a normal renal cell-derived cell line

The Journal of Toxicological Sciences
Tomofumi FujinoMakio Hayakawa

Abstract

The farnesoid X receptor (FXR) is a bile acid-activated nuclear receptor which is abundant in the liver, intestine, and kidney. FXR is a pivotal factor in cholesterol/bile acid homeostasis but is involved in the growth of hepatocellular carcinoma cells. In the present study, we investigated whether FXR is also involved in the growth of renal adenocarcinoma cells. The cell growth of renal adenocarcinoma cell line ACHN was inhibited by FXR knockdown and stimulated by FXR ligand, while that of a normal renal cell-derived cell line, HK-2, was not affected. The carcinoma-specific stimulation of cell growth by FXR was found to arise from down-regulation of p53 and p21/Cip1 mRNA expression. Our study showed that FXR stimulates proliferation of renal adenocarcinoma cells and that FXR knockdown is useful for growth suppression of renal adenocarcinoma without cytotoxicity to normal renal cells.

References

Nov 19, 1993·Cell·W S el-DeiryB Vogelstein
May 21, 1999·Science·M MakishimaB Shan
May 21, 1999·Science·D J ParksJ M Lehmann
Jun 9, 1999·Molecular Cell·H WangB M Forman
Sep 3, 2004·Journal of Lipid Research·Audrey SirventBart Staels
Nov 21, 2007·FEBS Letters·Yanqiao Zhang, Peter A Edwards
Sep 13, 2012·Journal of Biochemistry·Tomofumi FujinoMakio Hayakawa
Sep 30, 2015·Oncotarget·Fei GuoFengtian He

❮ Previous
Next ❯

Citations

Dec 24, 2018·Expert Opinion on Therapeutic Targets·Christos Masaoutis, Stamatios Theocharis
Feb 1, 2018·Oncotarget·John P PhelanFergal O'Gara
Dec 15, 2020·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Kyounghwa JungDonghun Shin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.